![logo](/logos/COLL.webp)
Collegium Pharmaceutical, Inc.
NASDAQ:COLL
37.19 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Collegium Pharmaceutical, Inc. |
Symbool | COLL |
Munteenheid | USD |
Prijs | 37.19 |
Beurswaarde | 1,198,031,222 |
Dividendpercentage | 0% |
52-weken bereik | 20.95 - 40.95 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Joseph J. Ciaffoni |
Website | https://www.collegiumpharma.com |
An error occurred while fetching data.
Over Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)